We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-13.72%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
-$2.4B
Cap. Flow
-$757M
Cap. Flow %
-8.1%
Top 10 Hldgs %
23.15%
Holding
300
New
33
Increased
109
Reduced
94
Closed
43

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.5M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$62.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$53.8M
4
ANET icon
Arista Networks
ANET
+$47M
5
BSX icon
Boston Scientific
BSX
+$45.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$112M
2
AMGN icon
Amgen
AMGN
+$102M
3
AAPL icon
Apple
AAPL
+$102M
4
ATVI
Activision Blizzard
ATVI
+$72.8M
5
FLEX icon
Flex
FLEX
+$70.4M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Financials 23.51%
3 Healthcare 21.25%
4 Communication Services 7.66%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXON
101
Axon Enterprise
AXON
$42B
$32.1M 0.34%
734,366
+218,160
+42% +$11.3M
MIME
102
DELISTED
Mimecast Limited
MIME
$31.8M 0.34%
946,401
+324,017
+52% +$11.3M
FIVN icon
103
FIVE9
FIVN
$2.01B
$31.4M 0.34%
719,132
+184,003
+34% +$7.4M
SRCL
104
DELISTED
Stericycle Inc
SRCL
$30.5M 0.33%
830,828
-141,840
-15% -$6.66M
CCL icon
105
Carnival Corporation Ltd
CCL
$37.6B
$30M 0.32%
608,426
+1,557
+0.3% +$89.2K
REGN icon
106
Regeneron Pharmaceuticals
REGN
$72.2B
$29.9M 0.32%
80,000
+15,000
+23% +$5.49M
MU icon
107
Micron Technology
MU
$917B
$29.2M 0.31%
920,658
-17,141
-2% -$650K
VAR
108
DELISTED
Varian Medical Systems, Inc.
VAR
$28.8M 0.31%
+254,379
New +$29.1M
ICLR icon
109
Icon
ICLR
$14.3B
$28.8M 0.31%
222,668
-25,356
-10% -$3.5M
MPWR icon
110
Monolithic Power Systems
MPWR
$62B
$26.9M 0.29%
231,282
-54,496
-19% -$6.52M
SCHW
111
Charles Schwab
SCHW
$182B
$26.7M 0.29%
642,328
-489,668
-43% -$22.1M
TXN icon
112
Texas Instruments
TXN
$251B
$26.5M 0.28%
280,102
-35,396
-11% -$3.43M
TMHC icon
113
Taylor Morrison
TMHC
$26.3M 0.28%
1,652,168
+10,106
+0.6% +$165K
CHGG icon
114
Chegg
CHGG
$111M
$26.2M 0.28%
921,787
+770,489
+509% +$20.7M
PCRX icon
115
Pacira BioSciences
PCRX
$1.06B
$25.8M 0.28%
600,425
+318,601
+113% +$14.9M
EG icon
116
Everest Group
EG
$15.8B
$25.5M 0.27%
117,000
-13,000
-10% -$2.83M
DATA
117
DELISTED
Tableau Software, Inc.
DATA
$25.4M 0.27%
211,597
+49,714
+31% +$5.56M
GG
118
DELISTED
Goldcorp Inc
GG
$24.4M 0.26%
+2,489,865
New +$24.2M
WFC icon
119
Wells Fargo
WFC
$263B
$23.8M 0.25%
516,412
-397,432
-43% -$20.4M
MRK icon
120
Merck
MRK
$331B
$23.4M 0.25%
321,159
-1,582,330
-83% -$112M
PRA
121
DELISTED
ProAssurance
PRA
$23.3M 0.25%
575,300
+300
+0.1% +$12.9K
PEGA icon
122
Pegasystems
PEGA
$4.83B
$22.6M 0.24%
945,092
-230,168
-20% -$6.04M
AUPH icon
123
Aurinia Pharmaceuticals
AUPH
$1.95B
$22.6M 0.24%
3,312,723
+501,207
+18% +$2.89M
FCX icon
124
Freeport-McMoran
FCX
$87B
$22.5M 0.24%
2,180,338
+331,988
+18% +$3.87M
ONC
125
BeOne Medicines Ltd
ONC
$34B
$22.4M 0.24%
160,000
+75,000
+88% +$9.95M
3 4
5
6 7

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Polar Capital held 300 positions worth $9.35B, down 20% from $11.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital withdrew a net $757M in Q4 2018, closing 43 positions and reducing 94 holdings. Its most notable exit was Activision Blizzard, an estimated $72.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polar Capital opened a new position in Boston Scientific worth $44.2M.

  • Polar Capital's largest Q4 2018 buy was Boston Scientific: 1,250,000 shares worth $44.2M.
  • Polar Capital added most to Danaher in Q4 2018, an estimated $66.5M increase.
  • Polar Capital's biggest Q4 2018 reduction was Merck, cutting an estimated $112M.
  • Polar Capital fully exited Activision Blizzard in Q4 2018, selling an estimated $72.8M.
  • Polar Capital's ten largest holdings make up 23% of its $9.35B portfolio in Q4 2018.
  • Polar Capital opened 33 new positions and closed 43 in Q4 2018.
  • Polar Capital's portfolio value fell 20% quarter-over-quarter to $9.35B.

Based on Polar Capital's 13F filing for Q4 2018, filed 14 Feb 2019.